BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7725160)

  • 1. [Biologic effects and possible therapeutic use of the granulocyte-macrophage colony-stimulating factor. Modern treatment of leukopenia].
    Jovanović-Mićić D; Beleslin DB; Bosnjak S
    Srp Arh Celok Lek; 1993; 121(8-12):152-4. PubMed ID: 7725160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Granulocyte colony-stimulating factor: biologic effects and possibilities of therapeutic use].
    Jovanović-Mićić D; Beleslin DB; Samardzić R; Bosnjak S
    Med Pregl; 1994; 47(3-4):102-4. PubMed ID: 7537846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosaminoglycans bind granulocyte-macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells.
    Modrowski D; Lomri A; Marie PJ
    J Cell Physiol; 1998 Oct; 177(1):187-95. PubMed ID: 9731758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human granulocyte-macrophage colony-stimulating factor (CSF), but not recombinant human granulocyte CSF, down-regulates the recombinant human stem cell factor-dependent differentiation of human fetal liver-derived mast cells.
    Du Z; Li Y; Xia H; Irani AM; Schwartz LB
    J Immunol; 1997 Jul; 159(2):838-45. PubMed ID: 9218602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced leukopenia].
    Shi YK; Sun Y; Su M
    Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):356-9. PubMed ID: 7895587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential clinical applications of rhGM-CSF in acute myeloid leukemia based on its biologic activity and receptor interaction.
    Lanza F; Rigolin GM; Castagnari B; Moretti S; Castoldi G
    Haematologica; 1997; 82(2):239-45. PubMed ID: 9175331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [High-dose chemoradiotherapy combined with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) followed by autologous peripheral blood stem cell transplantation (PBSCT) in a case of refractory acute myelogenous leukemia (AML)].
    Tanosaki R; Okamoto S; Takahashi S; Inoue T; Kikuno K; Aoki Y; Takada M; Irie S; Shimane M; Tojo A
    Rinsho Ketsueki; 1993 Aug; 34(8):946-51. PubMed ID: 8105115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
    Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
    Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Granulocyte-macrophage colony-stimulating factor (GM-CSF), preclinical and phase I clinical investigations].
    Shen B; Yang Z; Xu J
    Zhonghua Yi Xue Za Zhi; 1996 Sep; 76(9):654-7. PubMed ID: 9275545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activities of granulocyte-macrophage colony-stimulating factor and interleukin-3 on monocytes.
    Suzuki H; Katayama N; Ikuta Y; Mukai K; Fujieda A; Mitani H; Araki H; Miyashita H; Hoshino N; Nishikawa H; Nishii K; Minami N; Shiku H
    Am J Hematol; 2004 Apr; 75(4):179-89. PubMed ID: 15054806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human GM-CSF enhances T cell-mediated cytotoxic function after ABMT for hematological malignancies.
    Richard C; Alsar MJ; Calavia J; Bello-Fernandez C; Baro J; Loyola I; Rios R; Cuadrado MA; Gonzalez-Pardo C; Iriondo A
    Bone Marrow Transplant; 1993 Jun; 11(6):473-8. PubMed ID: 8334429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of herpes simplex virus (HSV) recurrent genital infection with recombinant human (rh) granulocyte-macrophage colony stimulating factor (GM-CSF): a case report.
    Altamura M; Geronimo MG; Nappi L; Ceci O; Loizzi P; Jirillo E
    Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):425-36. PubMed ID: 9436043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different response to recombinant human granulocyte-macrophage colony-stimulating factor in primary and secondary graft failure after bone marrow transplantation.
    Sierra J; Terol MJ; Urbano-Ispizua A; Rovira M; Marin P; Carreras E; Batlle M; Rozman C
    Exp Hematol; 1994 Jul; 22(7):566-72. PubMed ID: 8013572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know.
    Shi Y; Liu CH; Roberts AI; Das J; Xu G; Ren G; Zhang Y; Zhang L; Yuan ZR; Tan HS; Das G; Devadas S
    Cell Res; 2006 Feb; 16(2):126-33. PubMed ID: 16474424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous GM-CSF is involved as an autocrine growth factor for human osteoblastic cells.
    Modrowski D; Lomri A; Marie PJ
    J Cell Physiol; 1997 Jan; 170(1):35-46. PubMed ID: 9012783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical properties of yeast-derived versus Escherichia coli-derived granulocyte-macrophage colony-stimulating factor.
    Dorr RT
    Clin Ther; 1993; 15(1):19-29; discussion 18. PubMed ID: 8458048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of the c-fms proto-oncogene mediated by granulocyte/macrophage colony-stimulating factor (GM-CSF) in murine cell lines.
    Helftenbein G; Krusekopf K; Just U; Cross M; Ostertag W; Niemann H; Tamura T
    Oncogene; 1996 Feb; 12(4):931-5. PubMed ID: 8632916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.